Another Delaware Publicly Traded Company Proposes A Nevada Move
JD Supra: Mergers
SEPTEMBER 17, 2024
The company's common stock is listed on The NYSE American LLC stock exchange. Rather than convert, the company is proposing to effect the reincorporation by means of a merger with and into a wholly-owned subsidiary of the Company. The proposal also contemplates a simultaneous name change to “Channel Therapeutics Corporation”.
Let's personalize your content